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A recent meeting titled ‘‘Conserved Mechanisms of Stem Cell Control and Regeneration’’ was held at the
Biopharmaceutical Technology Center Institute (BTCI) in Madison, Wisconsin. The diversity of stem cells
and biological contexts discussed highlight the field’s rapid progress in deciphering the molecular basis of
stem cell functions and emphasize the challenges facing the future exploitation of these cells as therapeutic
vectors.The Metaphors of Stems and Niches
The way in which most biologists think about particularly com-
plex phenomena is oftentimes framed by a metaphor. For in-
stance, we refer to DNA as the blueprint of life, to proteins in
a cell as the machinery utilized to read the blueprint, and so
on. A similar situation applies to the undifferentiated cells found
in embryos and adults, capable of proliferating and producing
new cells that will eventually differentiate into one or more cell
types. We call these highly specialized cells ‘‘stem cells’’ (Ram-
alho-Santos and Willenbring, 2007), a translation from the word
‘‘stammzellen’’ used by German embryologists of the 1800s (Fig-
ure 1) and likely coined from the German word ‘‘stamm,’’ mean-
ing a group of people, families, or clans with a shared common
ancestor. More recently, the metaphor of a ‘‘stem’’ has been
joined by yet another metaphor, i.e., the niche, a concept intro-
duced by ecologists at the beginning of the 20th century to
describe a multidimensional space possessing a range of re-
sources needed by a given species (Pidwirny, 2008). Its applica-
tion to the study of stem cells was first proposed by Schofield as
a hypothesis in which ‘‘the stem cell is seen in association with
other cells which determine its behaviours. It becomes essen-
tially a fixed tissue cell. Its maturation is prevented and, as a re-
sult, its continued proliferation as a stem cell is assured’’ (Scho-
field, 1978). On the surface, both metaphors are appropriate, as
they have brought conceptual order to a rapidly growing field of
scientific endeavor. In the past few years, the ‘‘stem’’ concept
has helped spur a high degree of molecular resolution for in vitro
systems such as mammalian embryonic stem cells (ESCs). Such
understanding has culminated in the generation of ES-like cells
from adult mouse and human fibroblasts known as induced
pluripotent stem cells (iPSCs). The ‘‘niche’’ concept, on the other
hand, has provided a conceptual framework that has helped un-
cover differences between adult and embryonic stem cells. In
addition, the idea of niches has offered a platform for work using
invertebrate model systems that highlights the complex popula-
tion dynamics of stem cells and their equally intricate interac-
tions with in vivo microenvironments.
Yet, given all we have learned thus far, do these metaphors
promote or hinder the way we think about and experiment with
undifferentiated cells? It was this fountain, fed by such diverse
sources, from which the organizers of the 3rd annual Wisconsin
Stem Cell Meeting filled their cups. In fact, the broad distribution
and diversity of functions of stem cells among animals was theleitmotif of this thought-provoking conference held in Madison
on April 16, 2008, organized by Judith Kimble, Clive Svendsen,
the BTCI, and the University of Wisconsin Stem Cell and Regen-
erative Medicine Center. Given the brisk pace at which the field
of stem cells is moving, a meeting such as this provided a unique
opportunity not only to discuss the features of various stem cells,
but also to attempt an integration of the various types, functions,
and malfunctions of stem cells in the animal kingdom. Work on
stem cells of both invertebrates (fly, nematode, planarians) and
vertebrates (human, mouse, and fish) were discussed by leaders
in the field. The range of topics represented in this meeting ulti-
mately led the participants to reflect on the mechanistic relation-
ships that may or may not exist between embryonic, postembry-
onic (adult), and cancer stem cells. It also highlighted the
respective layers of complexity and differences that exist
between in vitro and in vivo stem cell biology, while providing
a forum to place current knowledge in a broader context not fre-
quently afforded by more specialized stem cell meetings.
ThePublic In Vitro andPrivate In Vivo Lives of StemCells
Due in part to their ease of cultivation and accessibility to exper-
imental manipulation (Figure 2A), much has been learned in re-
cent years about cultured mammalian ESCs. Given the high level
of molecular resolution that has been achieved, it is understand-
ably tempting to extend this knowledge to all other stem cells,
particularly those hidden away in the privacy of embryonic and
adult animal anatomy. For example, Rick Young (Whitehead,
MIT) discussed an impressive body of work aimed at defining
and understanding the regulatory interactions between tran-
scription factors, chromatin regulators, and signaling pathways
in cultured mammalian ESCs. Experiments involving both human
and mouse ESCs and a combination of extensive chromatin im-
munoprecipitation (ChIP) and high-throughput DNA sequencing
were discussed. Among the key findings were the following: (1)
the identification of a core, feed-forward, autoregulatory, tran-
scriptional regulatory loop involving OCT4, SOX2, and NANOG
(Boyer et al., 2005); (2) the specific co-occupancy of Polycomb
Group (PcG) repressor proteins with a subset of gene promoters
occupied by OCT4, SOX2, and NANOG to effect net repression
rather than activation (Boyer et al., 2006); and (3) that the terminal
component of the Wnt pathway (the transcription factor Tcf3) oc-
cupies promoters in the genome already populated by OCT4 and
NANOG, providing a model of how signaling pathways mayCell Stem Cell 3, July 2008 ª2008 Elsevier Inc. 25
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transcriptional regulatory circuitry (Cole et al., 2008).
This concept of ‘‘circuitry,’’ borrowed from electrical engineer-
ing, has now been applied to wet-lab research to synthesize the
complex interactions among transcription factors, chromatin
regulators, and signaling pathways that regulate the proliferation
and differentiation of mammalian ESCs (Jaenisch and Young,
2008). This is, in fact, an efficient and elegant way to visually dis-
play complex regulatory interactions. However, like all such rep-
resentations, it is difficult to model the temporal dimension in
two-dimensional diagrams, and yet the transformation of a cell
from an undifferentiated to a differentiated state does not occur
in a single quantum change. This failing is compounded by the
fact that ESCs maintained in vitro likely occupy a narrow, devel-
opmental space of sustained proliferation and self-renewal, in
which the coordination of multiple autonomous and nonautono-
mous inputs that drive differentiation in vivo are not easily cap-
tured. For instance, what activates the initial expression of
OCT4, SOX2, and NANOG? Where does the Wnt ligand come
from in the embryo? The answers to these questions require sim-
ilar studies performed before and after fertilization in order to
gain an understanding of when and how the identified core reg-
ulatory circuitry is established, briefly maintained, and eventually
dismantled in the developing embryo. Because literally millions
of cells are required to perform the ChIP-sequencing analyses
described, an in vivo analysis will have to resort to more sensitive
methods, such as single-cell microfluidics or other technologies
Figure 1. One of the Earliest Descriptions of
Undifferentiated Cells in Adult Animals
The plate illustrates longitudinal wax sections of
a freshwater turbellarian, and pseudocolored in
red are the abundant undifferentiated cells popu-
lating the body of the flatworm. Note that these
cells are labeled as ‘‘st’’ (yellow circles) or ‘‘stamm-
zellen’’ in the original manuscript by Keller. Modi-
fied from Keller (1894).
Figure 2. The Biological Scale of the
Problem: In Vitro to In Vivo Stem Cells
Stem cells can be studied easily at the micro scale
(A), due to their relative accessibility in vitro. How-
ever, the layers of complexity that also need to be
resolved in order to understand and influence
stem cell function at the macroscopic level (B)
are much harder to assay. These challenges
were a central theme to this symposium. Mouse
embryonic stem cells in (A) are at 335 magnifica-
tion. The idea for this figure is based on a slide
presented by Judith Kimble at the symposium.
aimed at profiling the genomic output of
single cells (Zhong et al., 2008).
These limitations are underscored by
the significantly more private (i.e., less ac-
cessible) lives of in vivo ESCs (Figure 2B).
This complexity was eloquently articu-
lated by Janet Rossant (University of Tor-
onto), who presented work on the characterization of the three
lineage-specific progenitors present in the early mouse embryo:
the trophectoderm and the internal cell mass (ICM)-derived epi-
blasts and primitive endoderm cells. As she and others have
shown previously, stem cells can be readily derived from each:
ESCs from the epiblast (EPI), trophoblast stem cells from the tro-
phectoderm, and extraembryonic endoderm (XEN) cells from the
primitive endoderm (PE) (Yamanaka et al., 2006). Thus, unam-
biguous delineation of the originating lineage is absolutely es-
sential if one wishes to correctly interpret the biological activities
of cells derived from early embryos. This is particularly apparent
in the case of the ICM, from which arise not only the EPI and PE,
but also all mammalian pluripotent ESCs derived to date. The
segregation of the EPI and PE lineages within the ICM was not
considered a problem in ESC derivation because all cells in the
ICM were thought to be homogeneous, each with the ability to
become either EPI or PE. However, Rossant’s work has unam-
biguously shown that the ICM of the mouse embryo is composed
of a heterogeneous population of cells that may have already be-
come lineage restricted prior to the blastocyst stage of mouse
embryogenesis (Chazaud et al., 2006). So why are only ESCs
and not XEN cells derived from the ICM in vitro? The most likely
explanation is that the derivation of ESCs is performed under
conditions that inhibit FGF signaling, which is a prerequisite for
PE development. These findings have direct implications to the
characterization of human ESCs, which are derived from the
ICM of the human blastocyst. Unlike mouse ESCs, human26 Cell Stem Cell 3, July 2008 ª2008 Elsevier Inc.
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promote PE and trophectoderm stem cell renewal in the mouse
(presence of FGF, activin, nodal). Moreover, Rossant also
pointed out that human ESCs express markers of the trophecto-
derm lineage (Xu et al., 2001). Because the lineages of the early
human embryo remain uncharacterized, the intriguing possibility
exists that the observed differences between human and mouse
ESCs may arise not from inherent differences in functionality be-
tween the two species, but rather from differences in the devel-
opmental stages of the human and mouse blastocyst from which
the lines were derived. Future work must consider the possibility
of generating a detailed lineage map of the early primate embryo
to address these important issues.
Memo to iPSCs: Don’t Forget to Call on Adult Stem Cells
The findings in cultured and in vivo mammalian stem cells argue
that a combination of these two primary modes of research is
necessary to understand the biology of undifferentiated cells
and should provide a robust platform to develop rational strate-
gies to utilize iPSCs either as therapeutic agents or as human
disease models. To this end, James Thomson (University of Wis-
consin, Madison) discussed both technical limitations and gaps
in our understanding that each need to be overcome if iPSCs are
to become clinically relevant. The current method of producing
iPSCs relies on the use of viral integration vectors, which could
potentially introduce mutations at the insertion site. Moreover,
expression of the exogenous genes introduced by the virus per-
sists at different levels even after the endogenous genes are re-
activated. Given the interest these cells have generated, one
would be taking little to no risk in predicting that these limitations
will be overcome in short order. More difficult to resolve will be
the barriers facing the use of iPSCs in cell-based transplantation
therapies. It remains to be seen whether iPSCs can functionally
integrate in diseased or injured tissues in a physiologically useful
way, or if the conditions that led to the death or degeneration of
the original cells can be overcome to allow the transplanted cells
to survive.
Addressing these issues will need at least as thorough an un-
derstanding of the adult conditions in which stem cells operate
as to what thus far has been achieved for ESCs. If an adult neu-
ron is required, for example, why not induce differentiated cells
to become adult rather than embryonic stem cells? If the core
transcriptional regulators of adult stem cells were to be eluci-
dated, could these be used instead of OCT4, NANOG, and
SOX2 to revert differentiated cells to the appropriate postembry-
onic developmental stage? In this regard, work from my own
laboratory on the planarian Schmidtea mediterranea aimed at
identifying genes involved in adult stem cell function and regen-
eration may inform this particular aspect of stem cell biology.
RNAi-based screening for genes that affect adult stem cell func-
tion in planarians, tissue homeostasis, regeneration, and the
functional integration of newly regenerated body part tissues
into pre-existing tissues (Reddien et al., 2005) offers an experi-
mental approach that broadly informs the search for regulatory
pathways and mechanisms that may be specific to the adult
rather than the embryonic condition. That such differences exist
between embryonic and adult stem cells was illustrated by Sean
Morrison (University of Michigan). Studies from his laboratory
have demonstrated a requirement for the PcG transcriptionalrepressor Bmi-1 in the postnatal maintenance of stem cells in
multiple tissues, including the central and peripheral nervous
systems. Bmi-1 is undetectable in ESCs but is expressed in
the stem cells of young and old adult mice (Molofsky et al.,
2003) and has been shown to modulate the senescence-associ-
ated genes Ink4a and Arf (Molofsky et al., 2006). The temporally
regulated overlapping transcriptional program that exists be-
tween Bmi-1, Ink4a, and Arf suggests the existence of age-de-
pendent, stem cell regulatory pathways absent in embryos and
capable of regulating lifelong physiological changes in popula-
tions of adult stem cells. Hence, studies aimed at understanding
the developmental origin and age of stem cells, and the function
of genes involved in adult stem cell function and regeneration,
will likely inform attempts to induce stage-appropriate multi-
potent stem cells, and to drive the therapeutic differentiation of
both ES and iPSCs.
A Wnt-Wnt Situation
It is difficult to imagine how the complexity of multicellular organ-
isms could possibly arise without robust cell-cell communica-
tion. Signaling pathways are essential in transmitting intercellular
information, and this point was independently and frequently
emphasized at the meeting by the recurrence of key roles for
the Wnt/b-catenin pathway in the autonomous and nonautono-
mous regulation of both embryonic and adult stem cells. In
ESCs, Young reported how the Wnt/b-catenin pathway trans-
duces developmental signals directly to the core regulatory cir-
cuitry of ESCs to influence the balance between pluripotency
and differentiation. Judith Kimble (University of Wisconsin, Mad-
ison) discussed genetic studies in which perturbation of this
pathway in non-stem cells negatively affects the development
of germ stem cells in Caenorhabditis elegans. Two of the three
genes identified code for genes associated with the Wnt/b-cate-
nin pathway (Sys-2/TCF and Sys-3/Nkx 2.5), while the remaining
gene (Sys-1) codes for a novel protein. Missing from this picture
was b-catenin, which is essential for mediating Wnt-activated
gene transcription. Although the SYS-1 amino acid sequence
was novel, in genetic and biochemical studies this molecule
functions as if it were b-catenin: SYS-1 was shown to bind to
the b-catenin-binding domain of TCF, and to coactivate TCF-de-
pendent transcription (Kidd et al., 2005). In fact, when SYS-1 was
crystallized on its own, or bound to TCF, its structural similarities
to human b-catenin were, simply put, astonishing (Liu et al.,
2008). The important discovery that SYS-1 is related to b-catenin
not by sequence but by structure suggests that additional diver-
gent b-catenins with potentially important cell signaling modula-
tion roles await discovery.
In planarians, b-catenin plays key roles in regulating antero-
posterior polarity of stem cell progeny in both intact and ampu-
tated animals. We discovered that abrogation of b-catenin by
RNAi results in animals that regenerate heads at posterior
ends, while abrogation of its inhibitor, APC, results in the regen-
eration of tails at anterior ends. Remarkably, even in un-
amputated animals, silencing b-catenin also disrupted the ante-
roposterior axis of the adult animal, resulting in a transformation
of the tail into a head and the eventual appearance of multiple
heads along the edges of the organism. Because planarian
stem cells give rise to all cell types in this organism, our discov-
eries suggest that the evolutionarily ancient b-catenin proteinCell Stem Cell 3, July 2008 ª2008 Elsevier Inc. 27
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the stem cell daughter cells will assume anterior or posterior
identity (Gurley et al., 2008). Altogether, the Wnt/b-catenin find-
ings from different embryonic and adult stem cell systems illus-
trate how a single signaling pathway can induce widely varying
outcomes, depending on the developmental context in which
the signal is received.
Rethinking Stem Cell Biology
Allan Spradling (Carnegie Institution of Washington and HHMI)
challenged the audience by stating that ‘‘the field of stem cells
has been too focused on stem cells.’’ Of course, he was referring
to the fact that an equally important aspect of stem cell function
is dictated not by the stem cells proper, but rather by the niches,
or microenvironments, in which they reside. In recent years,
many such microenvironments have been carefully defined in
the gonads of both the fruit fly Drosophila melanogaster and
the nematode C. elegans and also studied in the mammalian
central nervous system and the hematopoietic compartment,
among others (Morrison and Spradling, 2008). Based on obser-
vations of the dynamic interactions of stem cells (germline and
somatic) with their niches in Drosophila, Spradling defined two
general categories of niches: stromal and epithelial. The stromal
niche is represented by the interaction between the dividing
germ cells with the nondividing stromal cells of the ovary (Cap
cells) and the testis (Hub cells). The epithelial niche is a stroma-
free microenvironment and is populated by the follicle cell stem
cell (FSC). In this case, unique combinations of signals provided
by moving neighbors may yield a niche that is dynamic rather
than static.
Clearly, the dynamic, highly regulated interactions of stem
cells and their microenvironment will not be easily recapitulated
in vitro. For example, in stromal niches that harbor multiple adja-
cent stem cells such as those that maintain Drosophila germ
cells, replacement of lost stem cells is readily provided either
by the division of neighboring stem cells or by the developmental
reversion of transit-amplifying progeny back to a germ stem cell
state. In the case of the epithelial niche in which nonneighboring
FSCs reside in opposite sides of the Drosophila ovariole, FSC
daughters migrate across the ovariole to the other niche before
proliferating and contributing to the follicle cell monolayer. In
fact, the crossmigrating FSC progeny compete with the resident
FSC for niche occupancy and eventually become the source of
FSC replacement (Nystul and Spradling, 2007). Common to
both of these types of niches is the observation that individual
stem cells are often replaced and that such replacement may
be driven by competition. Under normal conditions such compe-
tition-driven stem cell replacement would favor the fittest stem
cell, ensuring the overall quality of the population. However, an
interesting corollary emerging from this dynamic model is the
possibility that precancerous mutations may spread by stem
cell competition, as well as by generating dysplastic lesions
(Nystul and Spradling, 2007). One likely place where such
a mechanism may operate is the mammalian intestine, in which
during development a crypt progenitor cell and its descendants
normally displace all other cells from the neonatal crypt, eventu-
ally reaching monoclonality (Schmidt et al., 1988). Under patho-
logical conditions, cancerous cells appear to outcompete
normal stem cells, resulting in the replacement of normal cells28 Cell Stem Cell 3, July 2008 ª2008 Elsevier Inc.by cancerous ones (Barker et al., 2007). Thus, it is likely that
the ontogeny of complex diseases such as cancer may depend
on similar dynamic interactions that exist between stem cells and
their microenvironments. If such dynamics are not elucidated,
the prospect of introducing stem cells grown in vitro into an adult
organism without causing disease will be severely hampered.
The dynamic nature of stem cells and their microenvironments
was also discussed by Ken Poss (Duke University) using the ze-
brafish heart as an experimental paradigm. Using transgenic re-
porters to trace both differentiated and undifferentiated cells,
Poss observed sustained proliferation of undifferentiated car-
diac progenitor cells after resection of the cardiac apex. These
cells also expressed the earliest markers of the embryonic
zebrafish heart field (nkx 2.5, tbx 20, and hand 2). In contrast to
the myocardium, in which changes in gene activation were re-
stricted to the plane of amputation, the entire adult epicardium
responded to injury by expressing the normally absent embry-
onic genes raldh2 and tbx18. Such reactivation of developmental
gene expression was followed by the epithelial-to-mesenchymal
transition of a subpopulation of epicardial cells, which then
invaded the wounded myocardium and subsequently differenti-
ated to provide new vasculature to regenerating muscle (Lepilina
et al., 2006). Interestingly, aspects of these regenerative events
appear to be recapitulated during normal cardiac homeostasis.
Pulse-chase labeling experiments revealed that the epicardium
recurrently contributes cells to the ventricular wall, and that inhi-
bition of FGF signaling depressed this epicardial supplementa-
tion of the ventricular wall, eventually leading to spontaneous
ventricular scarring (Wills et al., 2008). Combined with the ante-
roposterior phenotypes observed in planarians after abrogation
of b-catenin, the data demonstrate that cells can be encouraged
to alter their fates dramatically depending on what signals they
receive.
Prospects
It is clear that much remains unknown about the pluripotent
state, the cells that effect this activity, and the environments in
which they operate. It is also clear that the stem and niche met-
aphors have shaped the way in which biologists think about
these phenomena. Although these models have had a generally
positive impact on the field thus far, such metaphors have also
imparted a relatively linear rather than dialectic view onto stem
cell biology. For instance, in real life, the progeny of a group of
people cannot go back developmentally and replace their an-
cestors, nor can a sibling transition itself into another sibling.
Thus, the discovery that stem cell progeny can actually revert de-
velopmentally and reenter a stem cell state was immediately
considered remarkable by the field. Likewise, it was also unex-
pected to find that epicardial cells can undergo an epithelial-
to-mesenchymal transition in the adult heart. Such is the grip
of metaphors once they transmogrify from a descriptive tech-
nique to almost literal truths. Extending (and often overextend-
ing) such metaphors has brought a series of assumptions to
the field of stem cell biology that need to be constantly exam-
ined. As Arturo Rosenblueth and Norbert Wiener once wrote:
‘‘the price of metaphor is eternal vigilance’’ (Rosenblueth and
Wiener, 1945). The data discussed in this meeting demonstrate
that our understanding of stem cells both in vivo and in vitro
now approaches a level that demands re-evaluation of the
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biology. How profound the coming conceptual changes will be
to the way we think about undifferentiated cells and their micro-
environments may depend entirely on how vigilant we remain,
and how frequently and rigorously we are willing to check our
premises.
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